AVADEL PHARMACEUTICALS PLC Quarterly Common Stock, Shares, Issued from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Avadel Pharmaceuticals Plc quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q2 2024.
  • Avadel Pharmaceuticals Plc Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 96.2M shares, a 7.71% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 96.2M +6.88M +7.71% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 96.1M +31.6M +49% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 89.8M +26.9M +42.9% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 89.4M +28.5M +46.8% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 89.3M +30.3M +51.3% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 64.5M +5.45M +9.23% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 62.9M +4.26M +7.26% Dec 31, 2022 10-K 2024-02-29
Q3 2022 60.9M +2.27M +3.87% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 59M +550K +0.94% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 59M +544K +0.93% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 58.6M +224K +0.38% Dec 31, 2021 10-K 2023-03-29
Q3 2021 58.6M +373K +0.64% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 58.5M -5.05M -7.95% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 58.5M +15.6M +36.5% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 58.4M +15.5M +36% Dec 31, 2020 10-K 2022-03-16
Q3 2020 58.2M +15.4M +35.9% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 63.5M +20.8M +48.6% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 42.9M +95K +0.22% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 42.9M +207K +0.49% Dec 31, 2019 10-K 2021-03-09
Q3 2019 42.9M +437K +1.03% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 42.8M +615K +1.46% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 42.8M +696K +1.66% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 42.7M 0 0% Dec 31, 2018 10-K 2020-03-16
Q3 2018 42.4M +985K +2.38% Sep 30, 2018 10-Q 2018-11-05
Q2 2018 42.1M +713K +1.72% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 42.1M +686K +1.66% Mar 31, 2018 10-Q 2018-05-04
Q4 2017 42.7M +1.35M +3.26% Dec 31, 2017 10-Q 2019-08-09
Q3 2017 41.4M +194K +0.47% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 41.4M +194K +0.47% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 41.4M +139K +0.34% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 41.4M +130K +0.32% Dec 31, 2016 10-K 2018-03-16
Q3 2016 41.2M Sep 30, 2016 10-Q 2016-11-14
Q2 2016 41.2M +742K +1.83% Jun 30, 2016 10-Q 2016-08-15
Q1 2016 41.2M +988K +2.45% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 41.2M +1.05M +2.61% Dec 31, 2015 10-K 2017-03-28
Q2 2015 40.5M +1.92M +4.97% Jun 30, 2015 6-K 2015-12-31
Q1 2015 40.3M +1.99M +5.19% Mar 31, 2015 6-K 2015-07-10
Q4 2014 40.2M +14.6M +56.9% Dec 31, 2014 10-K 2016-03-15
Q3 2014 38.9M +13.5M +52.9% Sep 30, 2014 6-K 2014-11-17
Q2 2014 38.6M +13.1M +51.5% Jun 30, 2014 6-K 2014-08-08
Q1 2014 38.3M Mar 31, 2014 6-K 2014-07-08
Q4 2013 25.6M +197K +0.78% Dec 31, 2013 20-F/A 2015-10-01
Q3 2013 25.5M Sep 30, 2013 6-K 2014-01-15
Q2 2013 25.5M +308K +1.23% Jun 30, 2013 6-K 2013-12-06
Q4 2012 25.4M +453K +1.82% Dec 31, 2012 20-F/A 2014-04-30
Q2 2012 25.2M Jun 30, 2012 6-K 2012-12-14
Q1 2012 25.2M Mar 31, 2012 6-K 2012-09-13
Q4 2011 25M +317K +1.29% Dec 31, 2011 20-F 2013-04-30
Q4 2010 24.6M Dec 31, 2010 20-F 2012-04-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.